lisdexamfetamina adalvo 70 mg
pharmadox healthcare limited - malta - lisdexamfetaminum - caps. - 70 mg - psihostimulante si nootrope simpatomimetice cu actiune centrala
lisdexamfetamina stada 20 mg
stada arzneimittel ag - romania - lisdexamfetaminum - caps. - 20mg - psihostimulante si nootrope simpatomimetice cu actiune centrala
lisdexamfetamina stada 30 mg
stada arzneimittel ag - romania - lisdexamfetaminum - caps. - 30mg - psihostimulante si nootrope simpatomimetice cu actiune centrala
lisdexamfetamina stada 40 mg
stada arzneimittel ag - romania - lisdexamfetaminum - caps. - 40mg - psihostimulante si nootrope simpatomimetice cu actiune centrala
lisdexamfetamina stada 50 mg
stada arzneimittel ag - romania - lisdexamfetaminum - caps. - 50mg - psihostimulante si nootrope simpatomimetice cu actiune centrala
lisdexamfetamina stada 60 mg
stada arzneimittel ag - romania - lisdexamfetaminum - caps. - 60mg - psihostimulante si nootrope simpatomimetice cu actiune centrala
lisdexamfetamina stada 70 mg
stada arzneimittel ag - romania - lisdexamfetaminum - caps. - 70mg - psihostimulante si nootrope simpatomimetice cu actiune centrala
teysuno
nordic group b.v. - tegafur, gimeracil, oteracil - neoplasme de stomac - agenți antineoplazici - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.
flusamer 50 micrograme/250 micrograme/doza
elpen pharmaceutical co. inc (sa) - grecia - salmeterolum+fluticasonum - pulb. de inhalat cu doze presatbilite - 50 micrograme/250micrograme/doza - adrenergice inhalante adrenergice si alte med. pt. trat. bolilor obstructive c.r
flusamer 50 micrograme/500 micrograme/doza
elpen pharmaceutical co. inc (sa) - grecia - salmeterolum+fluticasonum - pulb. de inhalat cu doze presatbilite - 50 micrograme/500micrograme/doza - adrenergice inhalante adrenergice si alte med. pt. trat. bolilor obstructive c.r